According to Zhitong Finance App News, Ruipu Biotech (300119.SZ) announced that the company's holding subsidiary, Inner Mongolia Biwei Antai Biotechnology Co., Ltd. (“Biwei Antai”) recently received the “Veterinary Drug Product Approval Document” issued by the Ministry of Agriculture and Rural Affairs. Biwei Antai's “Bovine and Sheep Foot and Mouth Disease Type O, Type A, South Africa Type 1 Trivalent Inactivated Vaccine” and “Pig Foot and Mouth Disease Type O and South Africa Type 1 Bivalent Inactivated Vaccine” were approved for production.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.